Home › Urothelial (Transitional Cell) Carcinoma › Oregon › Beaverton
Urothelial (Transitional Cell) Carcinoma clinical trials in Beaverton, OR
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Beaverton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Providence Newberg Medical Center, Newberg · 15 mi away
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Compass Oncology - West, Tigard · 4 mi away
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- Northwest Cancer Specialists, P.C., Tigard · 4 mi away
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN24 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Edison, NJ18 studies
- Dallas, TX18 studies
- Los Angeles, CA17 studies
- Queens, NY16 studies
- Chicago, IL14 studies
- Boston, MA13 studies
- Arlington, VA13 studies
- San Antonio, TX13 studies
- Austin, TX10 studies
Other studies in Beaverton
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer8 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Prostate Cancer5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Endometrial Cancer4 studies
- Cancer (all types)3 studies
- Acute Myeloid Leukemia3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Diffuse Large B-Cell Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.